New PitchBook report, outlines how upcoming U.S. tariff policies are set to reshape biotech and pharma investment priorities. The analysis anticipates increased focus on domestic manufacturing and AI-enabled R&D platforms. While large pharmaceutical companies may deprioritize M&A in the short...
A new ethnographic preliminary insight from an ongoing study by Dr. Yael Assor delves into the Israeli Public Committee for the Enhancement of the Health Basket (PNAC) and its decision-making biases. Her research uncovers a fundamental yet rarely acknowledged tendency:...
Regulatory uncertainty disrupts progress, while merger-friendly policies create opportunities for growth; the industry's global ties face new challenges.Regulatory Uncertainty Meets Economic Promise...
Every patient in Israel faces the bureaucratic nightmare of inconsistent medical records between hospitals and HMOs. This issue is now the main obstacle to AI integration in healthcare. In a presentation by the Ministry of Health to the Knesset’s Health...
The FDA unveils groundbreaking initiatives to regulate AI in drug development and medical devices, prioritizing transparency, safety, and innovation....
New PitchBook report, outlines how upcoming U.S. tariff policies are set to reshape biotech and pharma investment priorities. The analysis anticipates increased focus on domestic manufacturing and AI-enabled R&D platforms. While large pharmaceutical companies may deprioritize M&A in the short...
A new ethnographic preliminary insight from an ongoing study by Dr. Yael Assor delves into the Israeli Public Committee for the Enhancement of the Health Basket (PNAC) and its decision-making biases. Her research uncovers a fundamental yet rarely acknowledged tendency:...
Regulatory uncertainty disrupts progress, while merger-friendly policies create opportunities for growth; the industry's global ties face new challenges.Regulatory Uncertainty Meets Economic Promise...
Every patient in Israel faces the bureaucratic nightmare of inconsistent medical records between hospitals and HMOs. This issue is now the main obstacle to AI integration in healthcare. In a presentation by the Ministry of Health to the Knesset’s Health...
The FDA unveils groundbreaking initiatives to regulate AI in drug development and medical devices, prioritizing transparency, safety, and innovation....
